Trump signs executive order establishing Women's Health Division at NIH, White House task force

Order rescinds prior administration's initiatives, directs focus on translating research into clinical care across all life stages

By LineZotpaper
Published
Updated
Read Time2 min
Sources5 outlets
President Donald Trump signed an executive order on October 19, 2026, led by First Lady Melania Trump, establishing a Women's Health Division within the National Institutes of Health and creating a White House Women's Health Task Force to coordinate federal efforts on research, prevention, diagnosis, treatment and care for women and girls across all stages of life.

The executive order directs the Secretary of Health and Human Services and the Director of the National Institutes of Health to establish a Women's Health Division within an appropriate NIH institute or center within 90 days. The division is tasked with increasing scientific review of understudied women's health conditions, advancing and coordinating research, promoting innovation in diagnostics and treatment, and facilitating translation of scientific discoveries into clinical practice.

The order also establishes the White House Women's Health Task Force, co-chaired by the Secretary of Health and Human Services and the White House Chief of Staff. The task force includes the Secretaries of War, Agriculture, Labor, Education, and Veterans Affairs, along with the heads of the Environmental Protection Agency, the Food and Drug Administration, the Centers for Disease Control and Prevention, the NIH, the Advanced Research Projects Agency for Health, and the Centers for Medicare and Medicaid Services.

According to the White House, the order rescinds initiatives of the prior administration to "broaden beyond research and prioritize translating research into improved clinical care that benefits women and girls."

The administration identified a range of conditions requiring more research including cardiovascular and heart disease, cancer, stroke, Alzheimer's Disease, autoimmune and inflammatory conditions, osteoporosis, mental health, chronic pain, endometriosis, fibroids, polyendocrine metabolic ovary syndrome, infertility, maternal health, menopause, neurological disorders, and aging.

The fact sheet accompanying the order highlighted other administration health initiatives including the launch of a new Dietary Guidelines for Americans with sections for pregnant and lactating women, expanded Health Savings Account access through the Working Families Tax Cuts Act, and the removal of broad "black box" warnings on Hormone Replacement Therapy products for menopause by the Food and Drug Administration in November 2025.

The administration also noted that 46 states have made investments in maternal health, including telehealth and remote patient monitoring for maternal care, obstetric workforce development, and postpartum care.

§

Analysis

Why This Matters

  • The order creates new federal infrastructure for women's health research and policy coordination, with a dedicated NIH division and a Cabinet-level task force mandated to deliver measurable results
  • By rescinding prior administration initiatives, the order signals a shift in approach that will affect how federal research dollars are allocated and how quickly findings move into clinical practice
  • The inclusion of conditions from infancy through aging represents a life-course approach that could reshape research priorities and clinical guidelines for decades

Background

Women's health research has historically received less funding and attention than research on conditions primarily affecting men. The NIH established the Office of Research on Women's Health in 1990, and Congress has periodically mandated inclusion of women in clinical trials. Despite progress, the administration's order cites persistent gaps in understanding and treating conditions that disproportionately or uniquely affect women. The new division sits within an existing NIH institute or center, with the task force operating out of the White House to coordinate across multiple agencies.

Key Perspectives

The Trump administration: The order represents a commitment to ensuring American women receive "the best scientifically-supported medical advice in the world" by enhancing, streamlining and elevating federal efforts in both research and its translation into health solutions. The administration frames the order as building on prior work while shifting emphasis toward clinical application. Researchers and advocacy groups: The order's broad mandate covering conditions from endometriosis and menopause to cardiovascular disease and Alzheimer's addresses longstanding calls for more attention to women's health. The effectiveness will depend on funding levels, staffing of the new division, and how the task force defines "measurable results."

What to Watch

  • Which NIH institute or center hosts the new Women's Health Division and who is appointed to lead it
  • The task force's first public hearings or roundtables, which may set priorities for the coming years
  • How the rescission of prior administration initiatives affects ongoing research projects and grant cycles

Sources

Checked

12 claims in this story checked against 1 source: 11 supported.

Show each claim
  1. SupportedTrump signs executive order establishing Women's Health Division at NIH, White House task forceNews – The White House: “By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered: ... Sec. 2. Establishment of the Women's Health Division Within the National Institutes of Health ... Sec. 3. Establishing the White House Women's Health Task Force”
  2. SupportedOrder rescinds prior administration's initiatives, directs focus on translating research into clinical care across all life stagesNews – The White House: “The Order rescinds the initiatives of the prior Administration in order to broaden beyond research and prioritize translating research into improved clinical care that benefits women and girls.”
  3. SupportedPresident Donald Trump signed an executive order on October 19, 2026News – The White House: “October 19, 2026”
  4. SupportedThe order was led by First Lady Melania TrumpNews – The White House: “President Donald J. Trump signed an Executive Order, led by First Lady Melania Trump”
  5. SupportedThe Women's Health Division must be established within 90 daysNews – The White House: “shall establish a Women’s Health Division within an appropriate institute or center within 90 days.”
  6. SupportedWhite House Women's Health Task Force co-chaired by Secretary of Health and Human Services and White House Chief of StaffNews – The White House: “co-chaired by the Secretary of Health and Human Services and the Assistant to the President and Chief of Staff.”
  7. SupportedTask force includes Secretaries of War, Agriculture, Labor, Education, Veterans Affairs, and heads of EPA, FDA, CDC, NIH, ARPAH, CMSNews – The White House: “the Secretary of War; the Secretary of Agriculture; the Secretary of Labor; the Secretary of Education; the Secretary of Veterans Affairs; the Administrator of the Environmental Protection Agency; the Commissioner of Food and Drugs; the Director of the Centers for Disease Control and Prevention; the Director of the National Institutes of Health; the Director of the Advanced Research Projects Agency for Health; the Administrator of the Centers for Medicare and Medicaid Services”
  8. SupportedOrder rescinds prior initiatives to 'broaden beyond research and prioritize translating research into improved clinical care that benefits women and girls.'News – The White House: “The Order rescinds the initiatives of the prior Administration in order to broaden beyond research and prioritize translating research into improved clinical care that benefits women and girls.”
  9. SupportedAdministration identified conditions requiring more research including cardiovascular and heart disease, cancer, stroke, Alzheimer's Disease, autoimmune and inflammatory conditions, osteoporosis, mental health, chronic pain, endometriosis, fibroids, polyendocrine metabolic ovary syndrome, infertility, maternal health, menopause, neurological disorders, and agingNews – The White House: “including cardiovascular and heart disease, cancer, stroke, Alzheimer’s Disease, autoimmune and inflammatory conditions, osteoporosis, mental health, chronic pain, endometriosis, fibroids, polyendocrine metabolic ovary syndrome, infertility, maternal health, menopause, neurological disorders, aging, and more.”
  10. SupportedFact sheet highlighted launch of new Dietary Guidelines for Americans with sections for pregnant and lactating womenNews – The White House: “Earlier this year, the Administration launched the new Dietary Guidelines for Americans with sections for pregnant and lactating women”
  11. SupportedExpanded Health Savings Account access through the Working Families Tax Cuts ActNews – The White House: “In his historic Working Families Tax Cuts Act, President Trump expanded access to health savings accounts for up to ten million people on Obamacare”
  12. Partly supportedRemoval of broad 'black box' warnings on Hormone Replacement Therapy products for menopause by FDA in November 2025News – The White House: “In November 2025, the Food and Drug Administration initiated the removal of broad and misleading 'black box' warnings on Hormone Replacement Therapy products for menopause.”

Zotpaper

Written by June Katz on the World desk. Claims checked by Ines Fairley, verification. Edited by Angus Burke, chief sub.

5 sources11 of 12 claims matched to a sourcefirst published 20 Oct, 3:45 am
Meet the newsroomHow we workSubscribe